Page last updated: 2024-08-21

nitrosomethylurethane and Disease Exacerbation

nitrosomethylurethane has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andarawewa, KL; Beau, F; Boulay, A; Dive, V; Guerin, E; Matziari, M; Rio, MC; Rousseau, B; Yiotakis, A	1

Other Studies

1 other study(ies) available for nitrosomethylurethane and Disease Exacerbation

Article	Year
Dosing and scheduling influence the antitumor efficacy of a phosphinic peptide inhibitor of matrix metalloproteinases. International journal of cancer, 2005, Feb-20, Volume: 113, Issue:5 Topics: Alkylating Agents; Animals; Apoptosis; Cell Proliferation; Colonic Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Kinetics; Lymphocytes, Tumor-Infiltrating; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Inbred BALB C; Nitrosomethylurethane; Oligopeptides; Peptide Fragments	2005

Article

Year

Dosing and scheduling influence the antitumor efficacy of a phosphinic peptide inhibitor of matrix metalloproteinases.

International journal of cancer, 2005, Feb-20, Volume: 113, Issue:5

Topics: Alkylating Agents; Animals; Apoptosis; Cell Proliferation; Colonic Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Kinetics; Lymphocytes, Tumor-Infiltrating; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Inbred BALB C; Nitrosomethylurethane; Oligopeptides; Peptide Fragments

2005